// App-Quantinova.ai

: Adoptive T-Cell Therapy for Acute Lymphoblastic Leukemia Targeting Multiple Tumor Associated Antigens

Researchers

Presenter

  • Swati Naik

Principal Investigators

  • Premal Lulla

  • Ifigeneia Tzannou

  • Robert A. Krance

  • George Carrum

  • Rammurti Kamble

  • Carlos A. Ramos

  • Catherine Robertson

  • Manik Kuvalekar

  • Ayumi Watanabe

  • Bambi J. Grilley

  • Juan F. Vera

  • Helen E. Heslop

  • Ann M. Leen

Medical Centers

  • Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Childrens Hospital, Houston Methodist Hospital, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

  • Graft-versus-host disease

Biomarkers

  • Alpha-fetoprotein

  • Breakpoint Cluster Region

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • L-selectin

  • Melanoma-associated antigen (MAGE)-A4

  • SSX Family Member 2

  • Twist-related protein 1

  • WT1 Transcription Factor

Drug/Treatment

  • Enfuvirtide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved